MedPage Today on MSN
Drug Therapy Holds Its Own Against LAAO in High-Risk Patients With Afib
Current guidelines for the U.S. and Europe have a recommendation of class 2b, level of evidence B or C for LAAO in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback